小儿川崎病并发冠状动脉损伤的特点及危险因素分析

Abstract
Figure/Table
References (17)
Related Citation (15)

Download: PDF (925 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To analyze the characteristics and risk factors of coronary artery lesions (CAL) in children with Kawasaki disease (KD), so as to provide a basis for clinical treatment and prognosis. Methods The relevant clinical data of 180 children with KD admitted to the Pediatrics Department, Yichun People′s Hospital from January 2020 to May 2021 was retrospectively analyzed. According to the presence or absence of CAL, the children were divided into observation group (combined CAL, 31 cases) and control group (non-CAL, 149 cases). Both groups were treated with intravenous gamma globulin (IVIG). Gender, age, and the start time of using IVIG were collected. Multivariate logistic analysis was performed on the data with statistical differences in univariate analysis to screen the risk factors for CAL in children with KD. Results Univariate analysis showed that age, start time of using IVIG, IVIG resistance, erythrocyte sedimentation rate (ESR), duration of fever, treatment time, C-reactive protein (CRP), alanine aminotransferase (ALT),interleukin-6 (IL-6), N-terminal pro-B-type natriuretic peptide (NT-proBNP) and serum sodium, decreased white blood cells (WBC), neutrophil-to-lymphocyte ratio (NLR) and platelet (PLT) were compared between two groups, the differences were statistically significant (P<0.05). Multivariate logistic analysis showed that duration of fever (β=1.254,OR=3.504, 95%CI=1.272-9.653), NT-proBNP (β=0.708, OR=2.030, 95%CI=1.170-3.521), WBC (β=0.869, OR=2.385,95%CI=1.332-4.286), PLT (β=0.657, OR=1.929, 95%CI=1.361-2.734), ESR (β=1.037, OR=2.821, 95%CI=1.533-5.819), and NLR (β=0.946, OR=2.575, 95%CI=1.262-5.256) were independent risk factors for CAL in children with KD (P<0.05). Conclusion Duration of fever, NT-proBNP, WBC, NLR, PLT and ESR are risk factors for CAL in children with KD. Attention should be paid to above-mentioned indicators in clinical treatment, and effective treatment should be performed timely.

Key words： Pediatric Kawasaki disease Coronary artery lesion Characteristic Risk factor

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	HUANG Li
	WEN Xuefeng
	TANG Xiaoyan
	HU Bing
	WU Junyong

Cite this article:

HUANG Li,WEN Xuefeng,TANG Xiaoyan, et al. Characteristics and risk factors of coronary artery lesions in children with Kawasaki disease[J]. 中国当代医药, 2022, 29(24): 5-8-13.

URL:

https://www.dangdaiyiyao.com/EN/ OR https://www.dangdaiyiyao.com/EN/Y2022/V29/I24/5

[1]	柴小娟，原新慧，李宇宁，等.肠道菌群与川崎病[J].安徽医药，2022，26（2）：213-216.
[2]	梁泳仙，张丽，汪周平，等.川崎病并发急腹症16 例临床分析[J].中华实用儿科临床杂志，2022，37（2）：103-106.
[3]	马飞艳，王娟，樊萍.川崎病患儿血清趋化素和缺血修饰清蛋白水平与冠状动脉损伤的相关性及在治疗中的应用价值[J].现代检验医学杂志，2021，36（3）：72-75.
[4]	方之洪，周慧，刘春，等.糖皮质激素联合乌司他丁治疗川崎病并冠状动脉损伤临床研究[J].中国药业，2020，29（14）：71-74.
[5]	郝京霞，张英谦，李博，等.细胞因子对川崎病患儿发生冠状动脉病变及静脉用丙种球蛋白抵抗的预测价值[J].中国医药，2022，17（2）：175-178.
[6]	刘庚英，汪顺雨，杜忠东.N 末端脑钠肽前体和脑钠肽对川崎病的诊断及并发冠状动脉损伤的早期预测价值[J].中国医学前沿杂志（电子版），2021，13（4）：87-91.
[7]	胡亚美.诸福棠实用儿科学[M].7 版.北京：人民卫生出版社，2002：132-135.
[8]	陈杰，周玉杰，赵梦华，等.实验室指标在不完全型川崎病冠状动脉损伤中的临床价值[J].检验医学，2019，34（11）：998-1001.
[9]	王潇.血清缺血修饰白蛋白、淀粉样蛋白A 及肌钙蛋白Ⅰ对川崎病患儿合并冠状动脉损伤的诊断价值[J].中国临床医生杂志，2020，48（11）：1366-1369.
[10]	王策，于宪一.婴儿川崎病的临床特点以及冠状动脉损伤危险因素分析[J].中国小儿急救医学，2019，26（11）：836-839.
[11]	陈琳，梁彩文，龙丽娜.川崎病患儿血清炎症因子、BNP、h-FABP 水平变化及其与冠状动脉损伤的关系[J].海南医学，2021，32（15）：1938-1941.
[12]	王志群，张雁，宋宁，等.川崎病合并冠状动脉损伤患儿血清同型半胱氨酸、N 末端B 型利钠肽前体、缺血修饰白蛋白水平变化及意义[J].中国临床医生杂志，2021，49（7）：859-862.
[13]	王复娟，吴良霞.川崎病冠状动脉损害相关危险因素分析[J].临床儿科杂志，2020，38（7）：481-484.
[14]	刘凡，丁艳，唐红霞，等.川崎病患儿冠状动脉损伤与血浆sFKN 水平的关系探讨[J].中西医结合心脑血管病杂志，2020，18（17）：2889-2891.
[15]	王凤娟，邢雅明.双嘧达莫辅助治疗川崎病患儿的疗效及对抗血小板聚集相关因子免疫功能CRP 及PCT 水平的影响[J].河北医学，2021，27（10）：1724-1729.
[16]	李东秀，黄植宁.小儿川崎病病因及发病机制研究现状[J].中外医学研究，2021，19（7）：191-194.
[17]	李丽骊.甲基强的松龙联合阿司匹林治疗对川崎病患儿临床效果及对患儿血清超敏C 反应蛋白、B 型钠尿肽水平的影响[J].中国当代医药，2021，28（12）：123-126.